| 注册
首页|期刊导航|解放军医学杂志|大麻二酚对大鼠非酒精性脂肪肝的治疗作用及机制

大麻二酚对大鼠非酒精性脂肪肝的治疗作用及机制

陈瑞 高晓刚 张雷 施晓敏 郭闻渊 朱有华 傅志仁

解放军医学杂志2017,Vol.42Issue(6):515-519,5.
解放军医学杂志2017,Vol.42Issue(6):515-519,5.DOI:10.11855/j.issn.0577-7402.2017.06.07

大麻二酚对大鼠非酒精性脂肪肝的治疗作用及机制

Therapeutic effect of cannabidiol on methionine-choline deficient diet-induced nonalcoholic steatohepatitis in rats and its mechanism

陈瑞 1高晓刚 1张雷 1施晓敏 1郭闻渊 1朱有华 1傅志仁1

作者信息

  • 1. 200003 上海 第二军医大学长征医院器官移植科
  • 折叠

摘要

Abstract

Objective To observe whether treatment with cannabidiol (CBD) affect nonalcoholic steatohepatitis (NASH) induced by methionine choline-deficient diet (MCD) in rats and investigate the underlying molecular mechanism. Methods Sixty-three adult male SD rats were randomly divided in to three groups as follows: Control group (rats fed with normal diet), MCD group (rats fed with MCD and MCD+CBD group [rats fed with MCD and treated with cannabidiol, 2mg/(kg.d), i.p.]. Ten weeks later, steatohepatitis and fibrosis were evaluated by hematoxylin-eosin and Masson staining, respectively. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured by using an automatic biochemical analyzer and hepatic levels of cholesterol and triacylglycerol were determined with kits. Autophagic flux in livers was evaluated by Western blotting. Results Treatment with cannabidiol reduced ratio of liver/body weightratio (4.2%±0.6% versus 3.1%±0.6%, P<0.05), histological scores (4.7±1.1 versus 2.2±0.5, P<0.05) and fibrosis (1.4%±0.4% versus 0.8%±0.3%, P<0.05) in rat livers, lowered levels of ALT (214.5±54.1U/L versus 92.1±36.0U/L, P<0.05) and AST (175.9±55.2U/L versus 70.8±24.9U/L, P<0.05) in serum, attenuated hepatic fat accumulation (cholesterol, 182.4±42.7mmol/mg protein versus 101.0±33.8mmol/mg protein, P<0.05; triglyceride, 71.4±12.5mmol/mg protein versus 38.7±11.1mmol/mg protein, P<0.05), and down-regulated mRNA expression of Col1A1 (2.9±0.4 versus 1.6±0.3, P<0.05) in livers of rats fed with MCD. Furthermore, cannabidiol led to the LC3 turnover (LC3-Ⅱ/LC3-I, 37.1±10.8 versus 71.2±17.1, P<0.05) and p62 decrease (202.4±40.9 versus 125.8±32.7, P<0.05) in the livers of MCD-fed rats. Conclusion Treatment with cannabidiol could relieve MCD-induced NASH in rats, at least in part, by autophagic flux promotion.

关键词

大麻二酚/非酒精性脂肪肝/自噬

Key words

cannabidiol/nonalcoholic steatohepatitis/autophagy

分类

医药卫生

引用本文复制引用

陈瑞,高晓刚,张雷,施晓敏,郭闻渊,朱有华,傅志仁..大麻二酚对大鼠非酒精性脂肪肝的治疗作用及机制[J].解放军医学杂志,2017,42(6):515-519,5.

基金项目

国家自然科学基金(81470900,31470873)This work was supported by the National Natural Science Foundation of China (81470900 and 31470873) (81470900,31470873)

解放军医学杂志

OA北大核心CSCDCSTPCD

0577-7402

访问量0
|
下载量0
段落导航相关论文